Antibody discovery could help create improved flu vaccines

September 13, 2016, Dana-Farber Cancer Institute
This colorized negative stained transmission electron micrograph (TEM) depicted some of the ultrastructural morphology of the A/CA/4/09 swine flu virus. Image: C. S. Goldsmith and A. Balish, CDC.

Dana-Farber Cancer Institute investigators report they have discovered a type of immune antibody that can rapidly evolve to neutralize a wide array of influenza virus strains - including those the body hasn't yet encountered.

The body's ability to make the adaptable antibody suggests potential strategies for creating improved or even "universal" influenza vaccines, according to a team led by Wayne A. Marasco, MD, PhD, a cancer immunologist and virologist at Dana-Farber, reporting in the journal Nature Communications.

The novel infection-fighting protein, named 3I14 mAb, is a "broadly neutralizing antibody," so-called because it can recognize and disable a diverse group of the 18 different strains of influenza virus that circulate around the globe. Marasco reported the discovery of broadly neutralizing antibodies in 2009.

According to the new report, the 3I14 antibody demonstrated it could neutralize the two main types of influenza A virus, group 1 and 2, and protected mice against lethal doses of the virus.

The 3I14 antibody is made by the human immune system's "memory" B cells - that circulate in the blood and reside in the spleen and bone marrow. When a person is exposed to an infectious agent, or receives a vaccine made from pieces of that agent, B cells that respond to the invaders can generate a memory of the specific type or strain. Pools of these memory B cells constitute a reserve defensive force that can quickly recognize and attack the microbe or virus should it enter the body again.

Unlike most infectious agents that can be protected against with a one-time vaccination, influenza is a shape-shifting virus that constantly and rapidly mutates, and also combines with other flu viruses from animals and birds. The shape changing occurs every flu season and is responsible for seasonal flu that we are vaccinated against yearly. The more dramatic changes that occur when new viruses emerge from animal and bird reservoirs are responsible for potentially more serious pandemics such as occurred in 2009.

The discovery of the new broadly neutralizing antibody came after Marasco and his colleagues took blood samples from seven blood bank donors that were shown to harbor these types of in their blood and challenged their immune B cells in the laboratory with an array of flu viruses. The researchers ultimately identified one B cell population "that recognized all the strains we screened against it," Marasco said. Sorting through the B cells' DNA, the scientists isolated the gene that carried the instructions for the 3I14 antibody.

The antibody proved that it could bind to the unchanging stem portion of flu viruses. And the antibody's genetic makeup gave it the flexibility to adapt or evolve, through mutations, to neutralize a myriad of .

The investigators challenged the B cells with a of the H5 type that the immune cells had never encountered. While the 3I14 antibody didn't initially bind strongly to the virus, the researchers introduced a single DNA mutation - a change in one letter of genetic code - that increased its binding strength to H5 by 10 times. "To our delight, we made one mutation and it did the job," Marasco said. "This was a simple mutation that would readily occur in nature."

What these results suggest, he said, is that the memory B cells of the immune system may be continuously diversifying through mutations. As a result, he said, through this mechanism, B cells "may lay down immunologic memory that can recognize all virus strains, present and future."

Ideally, Marasco said, vaccination strategies could be devised to build up in individuals a pool of memory B cells that aren't committed to making a single antibody type; instead, "you would hope to store B that have broad activity that, with minimum activity, can recognize all strains."

Explore further: Vaccine strategy induces antibodies that can target multiple influenza viruses

Related Stories

Vaccine strategy induces antibodies that can target multiple influenza viruses

July 22, 2016
Scientists have identified three types of vaccine-induced antibodies that can neutralize diverse strains of influenza virus that infect humans. The discovery will help guide development of a universal influenza vaccine, according ...

New flu strains and old antibodies: How sinful is 'original antigenic sin'?

August 18, 2016
Immune memory ensures a quick and specific response to previously encountered pathogens. However, for rapidly evolving pathogens like influenza virus, there is concern that recalled ('old') antibodies dominate and compromise ...

How antiviral antibodies become part of immune memory

August 15, 2016
Weapons production first, research later. During wartime, governments follow these priorities, and so does the immune system.

Intranasal flu vaccine produces long-lasting immune response in mice

July 19, 2016
Intranasal flu vaccines may be able to provide long-lasting protection against pandemic flu strains, according to a new study from immunologists at Columbia University Medical Center (CUMC).

Immune response to flu vaccine linked to recipients' ethnic background

February 16, 2016
How well a flu shot protects you from the virus can depend on your ethnic background and other inherited factors, report Dana-Farber Cancer Institute scientists.

New mouse model technology could speed the search for an AIDS vaccine

September 8, 2016
Researchers at Boston Children's Hospital have developed a technology to quickly generate mouse models for testing and tweaking potential HIV vaccines. Such models could speed up the quest for the AIDS field's "holy grail"— ...

Recommended for you

Bug guts shed light on Central America Chagas disease

October 18, 2018
In Central America, Chagas disease, or American trypanosomiasis, is spread by the "kissing bug" Triatoma dimidiata. By collecting DNA from the guts of these bugs, researchers reporting in PLOS Neglected Tropical Diseases ...

Rapid genomic sequencing of Lassa virus in Nigeria enabled real-time response to 2018 outbreak

October 18, 2018
Mounting a collaborative, real-time response to a Lassa fever outbreak in early 2018, doctors and scientists in Nigeria teamed up with researchers at Broad Institute of MIT and Harvard and colleagues to rapidly sequence the ...

Researchers cure drug-resistant infections without antibiotics

October 17, 2018
Biochemists, microbiologists, drug discovery experts and infectious disease doctors have teamed up in a new study that shows antibiotics are not always necessary to cure sepsis in mice. Instead of killing causative bacteria ...

How drug resistant TB evolved and spread globally

October 17, 2018
The most common form of Mycobacterium tuberculosis (TB) originated in Europe and spread to Asia, Africa and the Americas with European explorers and colonialists, reveals a new study led by UCL and the Norwegian Institute ...

Infectious disease consultation significantly reduces mortality of patients with bloodstream yeast infections

October 17, 2018
In a retrospective cohort study conducted at the University of Alabama at Birmingham Division of Infectious Diseases, patients with candidemia—a yeast infection in the bloodstream—had more positive outcomes as they relate ...

Marker may help target treatments for Crohn's patients

October 16, 2018
Crohn's disease (CD), a chronic inflammatory condition of the intestinal tract, has emerged as a global disease, with rates steadily increasing over the last 50 years. Experts have long suspected that CD likely represents ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.